Literature Cited

  • 1
    Awwad HK, Khagafy Y, Barsoum M: Accelerated versus conventional fractionation in the postoperative irradiation of locally advanced head and neck cancer: Influence of proliferation. Radiother Oncol 25: 261266, 1992.
  • 2
    Begg AC, Hofland I, Van Glabbeke M, Bartelink H, Horiot JC: Predictive value of potential doubling time for radiotherapy of head and neck tumor patients: Results from the EORTC cooperative trial 22851. Semin Radiat Oncol 1: 2225, 1992.
  • 3
    Begg AC, McNally NJ, Shrieve DC, Kärcher H: A method to measure the duration of DNA synthesis and the potential doubling time from a single sample. Cytometry 6: 620626, 1985.
  • 4
    Begg AC, Moonen L, Hofland I, Dessing M, Bartelink H: Human tumour cell kinetics using a monoclonal antibody against iododeoxyuridine: Intratumour sampling variation. Radiother Oncol 11: 337347, 1988.
  • 5
    Bennett MH, Wilson GD, Dische S: Tumour proliferation assessed by combined histological and flow cytometric analysis: Implications for therapy in squamous cell carcinoma in the head and neck. Br J Cancer 65: 870878, 1992.
  • 6
    Bourhis J, Wilson G, Wibault P, Bosq J, Chavaudra N, Janot F, Luboinski B, Eschwege F, Malaise E: In vivo measurement of the potential doubling time by flow cytometry in oropharyngeal cancer treated by conventional radiotherapy. Int J Radiat Oncol Biol Phys 26: 793799, 1993.
  • 7
    Corvo R, Giaretti W, Sanguineti G, Geido E, Orecchia R, Barra S, Margarino G, Bacigalupo A, Vitale V: Potential doubling time in head and neck tumors treated by primary radiotherapy—Preliminary evidence for a prognostic significance in local control. Int J Radiat Oncol Biol Phys 27: 11651172, 1993.
  • 8
    Haustermans K, Vanuytsel L, Geboes K, Lerut T, Van Thillo J, Leysen J, Cosemans W, van der Schueren E: In vivo cell kinetic measurements in human esophageal cancer: What can be learned from multiple biopsies? Eur J Cancer (in press).
  • 9
    Lochrin CA, Wilson GD, McNally NJ, Dische S, Saunders MI: Tumor cell kinetics, local tumor control, and accelerated radiotherapy: A preliminary report. Int J Radiat Oncol Biol Phys 24: 8791, 1992.
  • 10
    Rew DA, Campbell ID, Taylor I, Wilson GD: Proliferation indices of invasive breast carcinomas after in vivo 5-bromo-2′deoxyuridine labelling: A flow cytometric study of 75 tumours. Br J Surg 79: 335339, 1992.
  • 11
    Steel GG: Growth Kinetics of Tumors. Oxford University Press, London, 1977.
  • 12
    Van Oostrum IEA, Rozemuller E, Knol RFG, Erkens-Schulze S, Rutgers DH: Cell proliferation kinetics of six xenografted human cervix carcinomas: Comparison of autoradiography and bromodeoxyuridine labelling methods. Cell Tissue Kinet 23: 523544, 1990.
  • 13
    Wilson MS, West CM, Wilson GD, Roberts SA, James RD, Schofield PF: An assessment of the reliability and reproducibility of measurement of potential doubling times (Tpot) in human colorctal tumours. Br J Cancer 67: 754759, 1993.
  • 14
    White RA, Terry NHA: A quantitative method for evaluating bivariate flow cytometric data obtained using monoclonal antibodies to bromodeoxyuridine. Cytometry 13: 490495, 1992.
  • 15
    Withers HR, Taylor JMG, Maciejewski B: The hazard of tumour clonogen repopulation during radiotherapy. Acta Oncol 27: 131146, 1988.